Aviir Inc., a Menlo Park, Calif.-based developer of diagnostic tests for cardiovascular disease, has called down $11.45 million of a $25 million Series B round. Backers include Bay City Capital, Aberdare Ventures and New Leaf Ventures. www.aviir.com
Aviir Scores Series B
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.